In patients with PAH, a significant increase in plasma Ang II levels has been reported, accompanied by a decrease in Ang-(1–7) and Ang-(1–9) and a decrease in ACE2 activity [9,10]. Here, ACE2 is linked to pulmonary arterial hypertension.